Skip to content
★ Sign in to follow
AM

Allmed Medical Products Co.,Ltd Stock: price and insider trades · China

奥美医疗

CN·Mcap CN¥5.3BHealth Care

No insider purchase over the last 90 days. The latest, by 彭习云, was filed 20 May 2021.

Allmed Medical Products Co.,Ltd: what insiders have been doing

Allmed Medical Products Co.,Ltd, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). Allmed Medical Products Co.,Ltd has had no insider filing for more than a year; the last one goes back to 8 December 2022.

Our records for Allmed Medical Products Co.,Ltd go back to 2021, with 1 purchase and 2 sales on the open market in total.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.

Insider Decl.
3
Thresholds
n/a
Buy Volume
€4,900
1 ops. · all time
Sell Volume
€438,814
2 ops. · all time

Since the insiders bought

  • Filed 20 May 2021 · 2000 days ago · €4,900
    -35.0%
    Entry CN¥19.00 · Close at T+365 CN¥12.35

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 9,777 of 26,911 companies
58.3
score / 100
Value
63
Quality
54
FCF yld8.6%
Earn yld4.7%
EV/EBITDA10.7x
ROE7.1%
Gross mgn29%
Net mgn6.8%
Debt/EBITDA1.4x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥8.35
Analyst consensus
·
Income statement
RevenueCN¥3.7B
Gross profitCN¥1.1B29% margin
EBITDACN¥569.4M16% margin
Net incomeCN¥248.9M6.3% margin
Valuation
PER (trailing)20.9x
P/Book1.4x
Beta0.23
Balance sheet & cash
Market capCN¥5.3B
Total debtCN¥807.6M
Free Cash FlowCN¥456.8M
Debt / Equity33%
Profitability & ownership
ROE7.1%
ROA6.8%
% insiders62.4%
% institutions2.3%
Last declaration on 8 December 2022
Declarations3 total
  • ▼
    监事会主席Executives
    27,380 CNY15SZSE
    2,000 shares100.0% of flowA股XSHESZSE:173000006125741250
  • ▼
    董事Executives
    3M CNY15SZSE
    250,000 shares100.0% of flowA股XSHESZSE:173000005700107940
  • ▲
    监事Executives
    38,600 CNY15SZSE
    2,000 shares100.0% of flowA股XSHESZSE:173000004420840260
    Canonical exit: 18 Aug 2021 (T+90)

3 of 3 declarations

About Allmed Medical Products Co.,Ltd

奥美医疗 is a company focused on the healthcare and pharmaceutical sector, providing medical products and services. It is listed on the XSHE market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations